Medpace Historical Cash Flow

MEDP Stock  USD 314.21  2.40  0.76%   
Analysis of Medpace Holdings cash flow over time is an excellent tool to project Medpace Holdings future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 165 M or Begin Period Cash Flow of 124.1 M as it is a great indicator of Medpace Holdings ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Medpace Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medpace Holdings is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

About Medpace Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Medpace balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Medpace's non-liquid assets can be easily converted into cash.

Medpace Holdings Cash Flow Chart

At this time, Medpace Holdings' End Period Cash Flow is relatively stable compared to the past year. As of 03/28/2025, Net Borrowings is likely to grow to about 47.2 M, while Other Cashflows From Financing Activities is likely to drop slightly above 15.1 M.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Medpace Holdings to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Medpace Holdings operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Medpace Holdings' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Medpace Holdings current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.At this time, Medpace Holdings' End Period Cash Flow is relatively stable compared to the past year. As of 03/28/2025, Net Borrowings is likely to grow to about 47.2 M, while Other Cashflows From Financing Activities is likely to drop slightly above 15.1 M.
 2022 2023 2024 2025 (projected)
Free Cash Flow351.2M396.7M608.8M639.3M
Stock Based Compensation21.4M20.5M25.5M16.0M

Medpace Holdings cash flow statement Correlations

0.250.590.51-0.18-0.150.290.260.430.560.830.15-0.120.33-0.140.40.38-0.19-0.150.3-0.26
0.250.620.540.51-0.030.70.71-0.420.620.51-0.66-0.590.60.10.490.65-0.65-0.490.43-0.66
0.590.620.980.53-0.440.480.76-0.180.990.87-0.55-0.280.9-0.320.930.94-0.76-0.780.68-0.88
0.510.540.980.58-0.580.430.78-0.230.990.83-0.56-0.220.89-0.380.940.93-0.8-0.760.67-0.88
-0.180.510.530.58-0.410.390.7-0.520.570.39-0.76-0.210.48-0.460.530.57-0.74-0.430.4-0.61
-0.15-0.03-0.44-0.58-0.41-0.1-0.530.26-0.52-0.360.25-0.1-0.30.24-0.52-0.390.60.18-0.150.44
0.290.70.480.430.39-0.10.52-0.320.470.46-0.23-0.060.36-0.160.440.48-0.59-0.370.72-0.48
0.260.710.760.780.7-0.530.52-0.60.820.61-0.8-0.510.72-0.280.740.76-0.94-0.580.37-0.82
0.43-0.42-0.18-0.23-0.520.26-0.32-0.6-0.260.120.670.36-0.390.14-0.39-0.430.630.4-0.10.59
0.560.620.990.990.57-0.520.470.82-0.260.86-0.6-0.30.89-0.370.930.94-0.82-0.760.63-0.9
0.830.510.870.830.39-0.360.460.610.120.86-0.3-0.230.61-0.390.70.7-0.6-0.410.53-0.6
0.15-0.66-0.55-0.56-0.760.25-0.23-0.80.67-0.6-0.30.67-0.650.13-0.54-0.630.750.57-0.190.71
-0.12-0.59-0.28-0.22-0.21-0.1-0.06-0.510.36-0.3-0.230.67-0.35-0.28-0.14-0.310.330.140.130.35
0.330.60.90.890.48-0.30.360.72-0.390.890.61-0.65-0.35-0.210.920.96-0.71-0.910.64-0.94
-0.140.1-0.32-0.38-0.460.24-0.16-0.280.14-0.37-0.390.13-0.28-0.21-0.39-0.330.370.3-0.360.33
0.40.490.930.940.53-0.520.440.74-0.390.930.7-0.54-0.140.92-0.390.96-0.76-0.850.67-0.93
0.380.650.940.930.57-0.390.480.76-0.430.940.7-0.63-0.310.96-0.330.96-0.77-0.880.69-0.98
-0.19-0.65-0.76-0.8-0.740.6-0.59-0.940.63-0.82-0.60.750.33-0.710.37-0.76-0.770.59-0.50.83
-0.15-0.49-0.78-0.76-0.430.18-0.37-0.580.4-0.76-0.410.570.14-0.910.3-0.85-0.880.59-0.710.87
0.30.430.680.670.4-0.150.720.37-0.10.630.53-0.190.130.64-0.360.670.69-0.5-0.71-0.61
-0.26-0.66-0.88-0.88-0.610.44-0.48-0.820.59-0.9-0.60.710.35-0.940.33-0.93-0.980.830.87-0.61
Click cells to compare fundamentals

Medpace Holdings Account Relationship Matchups

Medpace Holdings cash flow statement Accounts

202020212022202320242025 (projected)
Change In Cash145.8M183.5M(433.0M)217.2M424.0M445.2M
Stock Based Compensation13.8M14.5M21.4M20.5M25.5M16.0M
Free Cash Flow227.3M235.1M351.2M396.7M608.8M639.3M
Change In Working Capital66.3M66.7M106.1M106.5M157.2M165.0M
Begin Period Cash Flow131.9M277.8M461.3M28.3M245.4M124.1M
Other Cashflows From Financing Activities16.0M17.6M22.1M11.4M15.9M15.1M
Depreciation19.5M21.1M22.3M26.3M29.3M30.2M
Other Non Cash Items13.2M16.3M15.9M22.4M19.1M12.2M
Capital Expenditures31.3M28.3M36.9M36.6M36.5M22.5M
Total Cash From Operating Activities258.7M263.3M388.1M433.4M608.8M639.3M
Change To Account Receivables(5.5M)(25.0M)(66.9M)(48.3M)2.2M2.4M
Net Income145.4M181.8M245.4M282.8M404.4M424.6M
Total Cash From Financing Activities(82.3M)(44.5M)(775.8M)(182.6M)(154.0M)(146.3M)
End Period Cash Flow277.8M461.3M28.3M245.4M669.4M702.9M
Sale Purchase Of Stock(98.3M)(62.1M)(847.8M)(144.0M)(169.9M)(161.4M)
Total Cashflows From Investing Activities(19.1M)(31.2M)(31.4M)(38.7M)(44.6M)(46.8M)
Change To Operating Activities7.5M11.0M846K48.5M55.7M58.5M
Other Cashflows From Investing Activities126K(3.1M)(1.9M)2.0M(28.3M)(26.9M)
Change To Netincome32.5M14.3M(22.0M)(3.1M)(2.8M)(2.7M)
Change To Liabilities26.6M21.6M28.0M58.9M67.7M71.1M
Change To Inventory21.3M5.5M25.0M66.2M76.1M79.9M
Investments(31.2M)(31.4M)(38.7M)(35.9M)(28.3M)(29.7M)
Cash And Cash Equivalents Changes108.8M145.2M187.5M(426.5M)(383.8M)(364.6M)
Cash Flows Other Operating39.4M63.4M79.3M131.5M151.2M158.7M
Change Receivables(21.3M)(5.5M)(25.0M)(66.9M)(60.2M)(57.2M)

Pair Trading with Medpace Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving together with Medpace Stock

  0.81A Agilent Technologies Earnings Call This WeekPairCorr
  0.68ME 23Andme HoldingPairCorr

Moving against Medpace Stock

  0.36VALN Valneva SE ADRPairCorr
The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.
The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Medpace Stock Analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.